Norway Clinical Diagnostics Market Size & Outlook, 2024-2030

Name: Norway Clinical Diagnostics Market Size & Outlook
Creator: Grand View Research
License: https://www.grandviewresearch.com/horizon/info/terms-of-use

The clinical diagnostics market in Norway is expected to reach a projected revenue of US$ 486.5 million by 2030. A compound annual growth rate of 5.4% is expected of Norway clinical diagnostics market from 2025 to 2030.

Norway clinical diagnostics product outlook (Revenue, USD million, 2018-2030)
- Instruments
  - Blood Gas Analyzers
  - Hematology Analyzers
  - Clinical Chemistry Analyzers
  - Immunoassay Analyzers
  - Urine Analyzers
  - Coagulation Analyzers
  - Microscopes
  - Flow Cytometers
  - PCR
  - Sequencing Instruments
  - ELISA
  - Mass Spectrometers
  - Automated Plate Readers
  - Spectrophotometers
  - Centrifuges
  - Electrophoresis Equipment
  - Point-of-Care Testing (POCT) Devices
  - Ultrasound Machines
  - CT (Computed Tomography) Scanners
  - MRI
  - X-ray Machines
  - Other Instruments
- Reagents
  - Taq Polymerase
  - MMLV RT
  - HIV RT
  - Hot start Taq Polymerase
  - UNG
  - RNase Inhibitors
  - Bst Polymerase
  - PCR Master Mix
  - Lyophilized Polymerase
  - T7 RNA Polymerase
  - Cas9 Enzyme
  - Acid Phosphatase
  - Alanine Aminotransferase
  - Amylase
  - Angiotensin Converting Enzyme
  - Aspartate Aminotransferase
  - Cholinesterase
  - Creatinine Kinase
  - Gamma Glutamyl Transferase
  - Lactate Dehydrogenase
  - Renin
  - Glucose Oxidase/Glucose Dehydrogenase
  - Urease
  - Lactate Oxidase
  - Horseradish Peroxide
  - Glutamate Oxidase
  - Other Reagents
- Software and Services
  - Laboratory Information Management Systems
  - Diagnostic Imaging Software
  - Data Analysis Software
  - In Vitro Diagnostics Quality Control
- Kits and assays
Norway clinical diagnostics application outlook (Revenue, USD million, 2018-2030)
- Infectious Diseases
  - HIV
  - Clostridium Difficile
  - HBV
  - Pneumonia or Streptococcus Associated Infections
  - Respiratory Syncytial Virus (RSV)
  - HPV
  - Influenza/Flu
  - HCV
  - MRSA
  - TB and Drug-resistant TB
  - HSV
  - COVID-19
  - Other Infectious Diseases
- Oncology
  - Breast Cancer
  - Colorectal Cancer
  - Cervical Cancer
  - Lung Cancer
  - Prostate Cancer
  - Skin Cancer
  - Blood Cancer
  - Kidney Cancer
  - Liver Cancer
  - Pancreatic Cancer
  - Ovarian Cancer
  - Other Oncology
- Cardiology
- Endocrinology
- Nephrology
- Autoimmune Diseases
- Hematology
- Toxicology
- Neurology
- Other Application
Norway clinical diagnostics end use outlook (Revenue, USD million, 2018-2030)
- Hospitals and Clinics
  - Inpatient and Outpatient
  - Emergency Rooms
- Diagnostic Laboratories
  - Independent Laboratories
  - Reference Laboratories
- Home Care Settings
  - At-home Testing Kits
  - Point-of-Care Devices
- Public Health Screening Programs

Norway Clinical Diagnostics Market Size & Outlook, 2024-2030

Sign up - it's easy, and free!